Revelation Biosciences Inc (REVB): Next-Year EPS Estimate 44.44%
As of 2026-06-04, Revelation Biosciences Inc (REVB) has a next-year EPS growth estimate of 44.44%.
On 2026-05-11, analyst consensus for REVB's next-year EPS growth shifted from 31.01% to 44.44% — a positive change of 13.43 percentage points. The revised estimate has been sustained across 19 subsequent trading sessions. Current-year growth is projected at 79.14%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 44.44%
- EPS growth this year
- 79.14%
- EPS next quarter (est)
- -$0.83
- Last price
- $1.05
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 44.44% | 79.14% | -$0.83 | $1.05 |
| 2026-06-03 | 44.44% | 79.14% | -$0.83 | $1.04 |
| 2026-06-02 | 44.44% | 79.14% | -$0.83 | $1.06 |
| 2026-06-01 | 44.44% | 79.14% | -$0.83 | $1.09 |
| 2026-05-31 | 44.44% | 79.14% | -$0.83 | $1.10 |
| 2026-05-28 | 44.44% | 79.14% | -$0.83 | $1.10 |
| 2026-05-27 | 44.44% | 79.14% | -$0.83 | $1.09 |
| 2026-05-26 | 44.44% | 79.14% | -$0.83 | $1.06 |
| 2026-05-25 | 44.44% | 79.14% | -$0.83 | $1.07 |
| 2026-05-24 | 44.44% | 79.14% | -$0.83 | $1.07 |
| 2026-05-21 | 44.44% | 79.14% | -$0.83 | $1.08 |
| 2026-05-20 | 44.44% | 79.14% | -$0.83 | $1.09 |
| 2026-05-19 | 44.44% | 79.14% | -$0.83 | $1.03 |
| 2026-05-18 | 44.44% | 79.14% | -$0.83 | $1.04 |
| 2026-05-17 | 44.44% | 79.14% | -$0.83 | $0.98 |
| 2026-05-14 | 44.44% | 79.14% | -$0.83 | $1.03 |
| 2026-05-13 | 44.44% | 79.14% | -$0.83 | $1.06 |
| 2026-05-12 | 44.44% | 79.14% | -$0.83 | $1.04 |
| 2026-05-11 | 44.44% | 79.14% | -$2.71 | $0.98 |
| 2026-05-10 | 31.01% | 78.12% | -$2.13 | $0.96 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Revelation Biosciences Inc's next-year EPS growth estimate?▾
As of 2026-06-04, Revelation Biosciences Inc (REVB) has a next-year EPS growth estimate of 44.44%, based on analyst consensus.
When was the latest EPS estimate revision for REVB?▾
The most recent revision occurred on 2026-05-11, when analysts adjusted the next-year EPS growth estimate from 31.01% to 44.44%.
What sector and industry does Revelation Biosciences Inc belong to?▾
Revelation Biosciences Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. REVB appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Revelation Biosciences Inc (REVB) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports